ANTIBE THERAPEUTICS INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.295 CAD | 0.00% |
|
0.00% | -68.28% |
| Apr. 24 | Antibe Therapeutics Inc. Announces Board Resignations | CI |
| Apr. 19 | Antibe Therapeutics Seeks Extension of Stay of Proceedings | MT |
Performance
| Current month | -34.44% | ||
| 1 month | -31.40% | ||
| 3 months | -70.20% | ||
| 6 months | -53.91% | ||
| Current year | -68.28% | ||
| 1 year | -45.37% | ||
| 3 years | -93.14% | ||
| 5 years | -91.19% | ||
| 10 years | -95.00% |
Volumes
marketsDaily volume
0
Estimated daily volume
0
Avg. Volume 20 sessions
101 521
Daily volume ratio
0.00
Avg. Volume 20 sessions CAD
29 948.70
Avg. Volume 20 sessions USD
21 892.50
Record volume 1
4 317 073
Record volume 2
2 948 911
Record volume 3
2 775 617
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (CAD)
15 627 012
Capitalization (USD)
11 423 346
Net sales (CAD)
0
Net sales (USD)
0
Number of employees
11
Sales / Employee (CAD)
0
Sales / Employee (USD)
0
Free-Float
92.06 %
Free-Float capitalization (CAD)
14 386 437
Free-Float capitalization (USD)
10 516 485
Average Daily Capital Traded
0.19%
Highs and lows
1 month
0.15
0.47
Current year
0.151.14
1 year
0.151.23
3 years
0.154.54
5 years
0.158.90
10 years
0.158.90
Indicators
Moving average 20 days
0.37
Moving average 50 days
0.67
Moving average 100 days
0.77
Price spread / (MMA20)
+25.59%
Price spread / (MMA50)
+127.22%
Price spread / (MMA100)
+160.58%
STIM
RSI 9 days
39.33
RSI 14 days
35.64
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| 0.00% | 0.00% | -68.28% | -45.37% | 11.42M | ||
| -0.06% | +0.81% | -2.31% | +22.94% | 103B | ||
| -0.84% | -1.52% | +0.56% | +13.52% | 95.28B | ||
| +0.90% | +3.56% | +1.69% | +0.60% | 22.15B | ||
| +0.58% | +0.46% | -17.37% | -21.15% | 21.02B | ||
| +2.04% | -2.57% | -9.30% | -29.49% | 18.15B | ||
| +3.17% | +1.71% | -41.01% | -37.19% | 16.74B | ||
| +3.38% | +18.58% | -14.85% | -37.58% | 16.05B | ||
| -1.28% | +3.02% | +3.21% | +32.39% | 13.68B | ||
| +1.08% | +11.37% | +33.54% | +5.31% | 12.17B | ||
| +1.98% | -1.93% | -24.71% | -33.33% | 8.24B | ||
| -0.75% | -3.05% | +7.90% | +77.79% | 7.76B | ||
| +0.95% | +0.62% | +0.17% | +51.30% | 7.71B | ||
| +7.91% | +17.17% | +299.30% | +280.10% | 8.19B | ||
| +0.72% | +5.24% | -1.21% | +28.46% | 6.99B | ||
| +0.83% | -3.27% | -21.74% | +75.93% | 6.85B | ||
| Average | +0.82% | +3.15% | +9.10% | +24.01% | ||
| Weighted average by Cap. | +0.32% | +1.68% | +2.75% | +15.67% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -68.28% | ||
| 2023 | +97.87% | ||
| 2022 | -28.79% | ||
| 2021 | -83.21% | ||
| 2020 | -12.67% | ||
| 2019 | +45.16% | ||
| 2018 | +113.79% | ||
| 2017 | -14.71% | ||
| 2016 | -5.56% | ||
| 2015 | -64.00% | ||
| 2014 | -5.66% | ||
| 2013 | -3.64% |
- Stock Market
- Equities
- ATE Stock
- Quotes Antibe Therapeutics Inc.
